Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,724,281 shares of the medical equipment provider's stock after selling 59,042 shares during the period. Intuitive Surgical accounts for 97.2% of Loomis Sayles & Co. L P's holdings, making the stock its 19th largest position. Loomis Sayles & Co. L P owned about 0.48% of Intuitive Surgical worth $900,006,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in ISRG. Vanguard Group Inc. lifted its stake in Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after purchasing an additional 360,591 shares in the last quarter. State Street Corp grew its position in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock valued at $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC lifted its position in Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock worth $2,541,356,000 after buying an additional 86,488 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of Intuitive Surgical by 1.7% during the 3rd quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider's stock valued at $1,530,318,000 after acquiring an additional 53,383 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Down 3.2 %

Intuitive Surgical stock traded down $16.06 during midday trading on Friday, reaching $491.84. The company's stock had a trading volume of 1,966,546 shares, compared to its average volume of 1,527,047. The company has a market cap of $175.18 billion, a P/E ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43. The business has a 50-day simple moving average of $556.28 and a 200-day simple moving average of $532.68. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Analysts Set New Price Targets

ISRG has been the topic of several analyst reports. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.